{"entity":{"type":"insider","cik":"0001704317","url":"/insider/0001704317","json_url":"/insider/0001704317.json","name":"Coric Vlad","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":44,"n_filings":13,"first":"2017-11-02","last":"2026-02-05","span_basis":"filed_date"},"name_variants":[{"name":"Coric Vlad","source":"filing","n_filings":13,"first_seen":"2017-11-02","last_seen":"2026-02-05"}],"transactions":[{"id":5882447,"accession":"0001628280-26-005907","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001628280-26-005907","line_url":"/filing/0001628280-26-005907#line-9","is_derivative":false,"issuer_cik":"0001704317","issuer_name":"Veradermics, Inc","issuer_ticker":"MANE","issuer_name_source":null,"issuer_url":"/issuer/0001704317","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":58823.0,"shares_display":"58,823","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":999991.0,"total_display":"999,991.00","shares_owned_after":319398.0,"shares_owned_after_display":"319,398","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-05","filed_date":"2026-02-05","scope":"insider"},{"id":5882445,"accession":"0001628280-26-005907","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001628280-26-005907","line_url":"/filing/0001628280-26-005907#line-8","is_derivative":false,"issuer_cik":"0001704317","issuer_name":"Veradermics, Inc","issuer_ticker":"MANE","issuer_name_source":null,"issuer_url":"/issuer/0001704317","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":58823.0,"shares_display":"58,823","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":999991.0,"total_display":"999,991.00","shares_owned_after":319398.0,"shares_owned_after_display":"319,398","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-05","filed_date":"2026-02-05","scope":"insider"},{"id":4037345,"accession":"0001704317-25-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001704317-25-000004","line_url":"/filing/0001704317-25-000004#line-2","is_derivative":false,"issuer_cik":"0001704317","issuer_name":"Biohaven Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001704317","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":333333.0,"shares_display":"333,333","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":2499997.5,"total_display":"2,499,997.50","shares_owned_after":1195275.0,"shares_owned_after_display":"1,195,275","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-17","scope":"insider"},{"id":4037342,"accession":"0001704317-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001704317-25-000004","line_url":"/filing/0001704317-25-000004#line-1","is_derivative":false,"issuer_cik":"0001704317","issuer_name":"Biohaven Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001704317","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":333333.0,"shares_display":"333,333","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":2499997.5,"total_display":"2,499,997.50","shares_owned_after":740546.0,"shares_owned_after_display":"740,546","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-17","scope":"insider"},{"id":2334322,"accession":"0001935979-24-000077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001935979-24-000077","line_url":"/filing/0001935979-24-000077#line-1","is_derivative":false,"issuer_cik":"0001704317","issuer_name":"Biohaven Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001704317","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21052.0,"shares_display":"21,052","price_per_share":47.5,"price_display":"47.50","price_state":"stated","total_value":999970.0,"total_display":"999,970.00","shares_owned_after":861942.0,"shares_owned_after_display":"861,942","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-02","filed_date":"2024-10-03","scope":"insider"},{"id":2357481,"accession":"0001562180-24-003493","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-003493","line_url":"/filing/0001562180-24-003493#line-1","is_derivative":false,"issuer_cik":"0001704317","issuer_name":"Biohaven Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001704317","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":121951.0,"shares_display":"121,951","price_per_share":41.0,"price_display":"41.00","price_state":"stated","total_value":4999991.0,"total_display":"4,999,991.00","shares_owned_after":1788417.0,"shares_owned_after_display":"1,788,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-22","filed_date":"2024-04-23","scope":"insider"},{"id":7814465,"accession":"0001562180-23-007246","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-23-007246","line_url":"/filing/0001562180-23-007246#line-2","is_derivative":false,"issuer_cik":"0001704317","issuer_name":"Biohaven Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001704317","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":113637.0,"shares_display":"113,637","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":2500014.0,"total_display":"2,500,014.00","shares_owned_after":1657031.0,"shares_owned_after_display":"1,657,031","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-05","filed_date":"2023-10-10","scope":"insider"},{"id":7814463,"accession":"0001562180-23-007246","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-007246","line_url":"/filing/0001562180-23-007246#line-1","is_derivative":false,"issuer_cik":"0001704317","issuer_name":"Biohaven Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001704317","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":340908.0,"shares_display":"340,908","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":7499976.0,"total_display":"7,499,976.00","shares_owned_after":833120.0,"shares_owned_after_display":"833,120","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-05","filed_date":"2023-10-10","scope":"insider"},{"id":6328896,"accession":"0001562180-22-007386","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-22-007386","line_url":"/filing/0001562180-22-007386#line-1","is_derivative":false,"issuer_cik":"0001704317","issuer_name":"Biohaven Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001704317","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25800.0,"shares_display":"25,800","price_per_share":15.9688,"price_display":"15.97","price_state":"stated","total_value":411995.04,"total_display":"411,995.04","shares_owned_after":1543394.0,"shares_owned_after_display":"1,543,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-31","filed_date":"2022-11-01","scope":"insider"},{"id":6275588,"accession":"0001562180-22-007373","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-22-007373","line_url":"/filing/0001562180-22-007373#line-2","is_derivative":false,"issuer_cik":"0001704317","issuer_name":"Biohaven Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001704317","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":14.8242,"price_display":"14.82","price_state":"stated","total_value":1482420.0,"total_display":"1,482,420.00","shares_owned_after":109565.0,"shares_owned_after_display":"109,565","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-28","filed_date":"2022-10-31","scope":"insider"},{"id":6275584,"accession":"0001562180-22-007373","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-22-007373","line_url":"/filing/0001562180-22-007373#line-1","is_derivative":false,"issuer_cik":"0001704317","issuer_name":"Biohaven Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001704317","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":41930.0,"shares_display":"41,930","price_per_share":14.8665,"price_display":"14.87","price_state":"stated","total_value":623352.345,"total_display":"623,352.34","shares_owned_after":1517594.0,"shares_owned_after_display":"1,517,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-28","filed_date":"2022-10-31","scope":"insider"},{"id":6978606,"accession":"0001562180-22-007332","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-22-007332","line_url":"/filing/0001562180-22-007332#line-1","is_derivative":false,"issuer_cik":"0001704317","issuer_name":"Biohaven Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001704317","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":853380.0,"shares_display":"853,380","price_per_share":10.5,"price_display":"10.50","price_state":"stated","total_value":8960490.0,"total_display":"8,960,490.00","shares_owned_after":1475664.0,"shares_owned_after_display":"1,475,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-25","filed_date":"2022-10-26","scope":"insider"},{"id":6655834,"accession":"0001562180-22-007115","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001562180-22-007115","line_url":"/filing/0001562180-22-007115#line-9","is_derivative":false,"issuer_cik":"0001704317","issuer_name":"Biohaven Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001704317","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80907.0,"shares_display":"80,907","price_per_share":10.8253,"price_display":"10.83","price_state":"stated","total_value":875842.5471,"total_display":"875,842.55","shares_owned_after":437883.0,"shares_owned_after_display":"437,883","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-05","filed_date":"2022-10-06","scope":"insider"},{"id":6655831,"accession":"0001562180-22-007115","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001562180-22-007115","line_url":"/filing/0001562180-22-007115#line-8","is_derivative":false,"issuer_cik":"0001704317","issuer_name":"Biohaven Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001704317","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80606.0,"shares_display":"80,606","price_per_share":10.8169,"price_display":"10.82","price_state":"stated","total_value":871907.0414,"total_display":"871,907.04","shares_owned_after":344820.0,"shares_owned_after_display":"344,820","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-05","filed_date":"2022-10-06","scope":"insider"},{"id":6655829,"accession":"0001562180-22-007115","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001562180-22-007115","line_url":"/filing/0001562180-22-007115#line-7","is_derivative":false,"issuer_cik":"0001704317","issuer_name":"Biohaven Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001704317","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":73331.0,"shares_display":"73,331","price_per_share":8.8234,"price_display":"8.82","price_state":"stated","total_value":647028.7454,"total_display":"647,028.75","shares_owned_after":322461.0,"shares_owned_after_display":"322,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-05","filed_date":"2022-10-06","scope":"insider"},{"id":6655826,"accession":"0001562180-22-007115","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001562180-22-007115","line_url":"/filing/0001562180-22-007115#line-6","is_derivative":false,"issuer_cik":"0001704317","issuer_name":"Biohaven Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001704317","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":73005.0,"shares_display":"73,005","price_per_share":8.8231,"price_display":"8.82","price_state":"stated","total_value":644130.4155,"total_display":"644,130.42","shares_owned_after":229755.0,"shares_owned_after_display":"229,755","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-05","filed_date":"2022-10-06","scope":"insider"},{"id":6655824,"accession":"0001562180-22-007115","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-22-007115","line_url":"/filing/0001562180-22-007115#line-5","is_derivative":false,"issuer_cik":"0001704317","issuer_name":"Biohaven Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001704317","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":54329.0,"shares_display":"54,329","price_per_share":11.8282,"price_display":"11.83","price_state":"stated","total_value":642614.2778,"total_display":"642,614.28","shares_owned_after":492212.0,"shares_owned_after_display":"492,212","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-05","filed_date":"2022-10-06","scope":"insider"},{"id":6655821,"accession":"0001562180-22-007115","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-22-007115","line_url":"/filing/0001562180-22-007115#line-4","is_derivative":false,"issuer_cik":"0001704317","issuer_name":"Biohaven Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001704317","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":52523.0,"shares_display":"52,523","price_per_share":11.7884,"price_display":"11.79","price_state":"stated","total_value":619162.1332,"total_display":"619,162.13","shares_owned_after":397343.0,"shares_owned_after_display":"397,343","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-05","filed_date":"2022-10-06","scope":"insider"},{"id":6655818,"accession":"0001562180-22-007115","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-22-007115","line_url":"/filing/0001562180-22-007115#line-3","is_derivative":false,"issuer_cik":"0001704317","issuer_name":"Biohaven Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001704317","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34515.0,"shares_display":"34,515","price_per_share":9.9042,"price_display":"9.90","price_state":"stated","total_value":341843.463,"total_display":"341,843.46","shares_owned_after":356976.0,"shares_owned_after_display":"356,976","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-05","filed_date":"2022-10-06","scope":"insider"},{"id":6655814,"accession":"0001562180-22-007115","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-22-007115","line_url":"/filing/0001562180-22-007115#line-2","is_derivative":false,"issuer_cik":"0001704317","issuer_name":"Biohaven Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001704317","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34459.0,"shares_display":"34,459","price_per_share":9.8949,"price_display":"9.89","price_state":"stated","total_value":340968.3591,"total_display":"340,968.36","shares_owned_after":264214.0,"shares_owned_after_display":"264,214","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-05","filed_date":"2022-10-06","scope":"insider"},{"id":6655809,"accession":"0001562180-22-007115","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-22-007115","line_url":"/filing/0001562180-22-007115#line-1","is_derivative":false,"issuer_cik":"0001704317","issuer_name":"Biohaven Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001704317","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2100.0,"shares_display":"2,100","price_per_share":12.3467,"price_display":"12.35","price_state":"stated","total_value":25928.07,"total_display":"25,928.07","shares_owned_after":399443.0,"shares_owned_after_display":"399,443","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-05","filed_date":"2022-10-06","scope":"insider"},{"id":7950241,"accession":"0001209191-19-039193","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-039193","line_url":"/filing/0001209191-19-039193#line-1","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":40.22,"price_display":"40.22","price_state":"stated","total_value":201100.0,"total_display":"201,100.00","shares_owned_after":19130.0,"shares_owned_after_display":"19,130","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-26","filed_date":"2019-06-26","scope":"insider"},{"id":8118339,"accession":"0001209191-19-019521","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-19-019521","line_url":"/filing/0001209191-19-019521#line-6","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16110.0,"shares_display":"16,110","price_per_share":50.02,"price_display":"50.02","price_state":"stated","total_value":805822.2,"total_display":"805,822.20","shares_owned_after":475000.0,"shares_owned_after_display":"475,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-14","filed_date":"2019-03-14","scope":"insider"},{"id":8118338,"accession":"0001209191-19-019521","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-019521","line_url":"/filing/0001209191-19-019521#line-5","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15783.0,"shares_display":"15,783","price_per_share":50.03,"price_display":"50.03","price_state":"stated","total_value":789623.49,"total_display":"789,623.49","shares_owned_after":440000.0,"shares_owned_after_display":"440,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-14","filed_date":"2019-03-14","scope":"insider"},{"id":8118334,"accession":"0001209191-19-019521","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-019521","line_url":"/filing/0001209191-19-019521#line-4","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8262.0,"shares_display":"8,262","price_per_share":50.02,"price_display":"50.02","price_state":"stated","total_value":413265.24,"total_display":"413,265.24","shares_owned_after":455783.0,"shares_owned_after_display":"455,783","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-13","filed_date":"2019-03-14","scope":"insider"},{"id":8118329,"accession":"0001209191-19-019521","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-019521","line_url":"/filing/0001209191-19-019521#line-3","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7883.0,"shares_display":"7,883","price_per_share":50.02,"price_display":"50.02","price_state":"stated","total_value":394307.66,"total_display":"394,307.66","shares_owned_after":491110.0,"shares_owned_after_display":"491,110","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-13","filed_date":"2019-03-14","scope":"insider"},{"id":8118325,"accession":"0001209191-19-019521","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-019521","line_url":"/filing/0001209191-19-019521#line-2","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26007.0,"shares_display":"26,007","price_per_share":50.15,"price_display":"50.15","price_state":"stated","total_value":1304251.05,"total_display":"1,304,251.05","shares_owned_after":498993.0,"shares_owned_after_display":"498,993","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-12","filed_date":"2019-03-14","scope":"insider"},{"id":8118321,"accession":"0001209191-19-019521","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-019521","line_url":"/filing/0001209191-19-019521#line-1","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25955.0,"shares_display":"25,955","price_per_share":50.15,"price_display":"50.15","price_state":"stated","total_value":1301643.25,"total_display":"1,301,643.25","shares_owned_after":464045.0,"shares_owned_after_display":"464,045","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-12","filed_date":"2019-03-14","scope":"insider"},{"id":6725828,"accession":"0001209191-18-034777","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-034777","line_url":"/filing/0001209191-18-034777#line-6","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8611.0,"shares_display":"8,611","price_per_share":35.04,"price_display":"35.04","price_state":"stated","total_value":301729.44,"total_display":"301,729.44","shares_owned_after":525000.0,"shares_owned_after_display":"525,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-01","filed_date":"2018-06-01","scope":"insider"},{"id":6725825,"accession":"0001209191-18-034777","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-18-034777","line_url":"/filing/0001209191-18-034777#line-5","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5229.0,"shares_display":"5,229","price_per_share":35.04,"price_display":"35.04","price_state":"stated","total_value":183224.16,"total_display":"183,224.16","shares_owned_after":525000.0,"shares_owned_after_display":"525,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-01","filed_date":"2018-06-01","scope":"insider"},{"id":6725822,"accession":"0001209191-18-034777","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-034777","line_url":"/filing/0001209191-18-034777#line-4","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18971.0,"shares_display":"18,971","price_per_share":35.01,"price_display":"35.01","price_state":"stated","total_value":664174.71,"total_display":"664,174.71","shares_owned_after":530229.0,"shares_owned_after_display":"530,229","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-31","filed_date":"2018-06-01","scope":"insider"},{"id":6725819,"accession":"0001209191-18-034777","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-034777","line_url":"/filing/0001209191-18-034777#line-3","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15648.0,"shares_display":"15,648","price_per_share":35.01,"price_display":"35.01","price_state":"stated","total_value":547836.48,"total_display":"547,836.48","shares_owned_after":533611.0,"shares_owned_after_display":"533,611","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-31","filed_date":"2018-06-01","scope":"insider"},{"id":6725816,"accession":"0001209191-18-034777","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-034777","line_url":"/filing/0001209191-18-034777#line-2","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":28000.0,"total_display":"28,000.00","shares_owned_after":549200.0,"shares_owned_after_display":"549,200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-30","filed_date":"2018-06-01","scope":"insider"},{"id":6725813,"accession":"0001209191-18-034777","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-034777","line_url":"/filing/0001209191-18-034777#line-1","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":741.0,"shares_display":"741","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":25935.0,"total_display":"25,935.00","shares_owned_after":549259.0,"shares_owned_after_display":"549,259","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-30","filed_date":"2018-06-01","scope":"insider"},{"id":5320867,"accession":"0001209191-17-058948","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-17-058948","line_url":"/filing/0001209191-17-058948#line-10","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18074.0,"shares_display":"18,074","price_per_share":29.1,"price_display":"29.10","price_state":"stated","total_value":525953.4,"total_display":"525,953.40","shares_owned_after":581926.0,"shares_owned_after_display":"581,926","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-01","filed_date":"2017-11-02","scope":"insider"},{"id":5320864,"accession":"0001209191-17-058948","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-17-058948","line_url":"/filing/0001209191-17-058948#line-9","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18074.0,"shares_display":"18,074","price_per_share":29.1,"price_display":"29.10","price_state":"stated","total_value":525953.4,"total_display":"525,953.40","shares_owned_after":581926.0,"shares_owned_after_display":"581,926","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-01","filed_date":"2017-11-02","scope":"insider"},{"id":5320862,"accession":"0001209191-17-058948","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-17-058948","line_url":"/filing/0001209191-17-058948#line-8","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6926.0,"shares_display":"6,926","price_per_share":29.62,"price_display":"29.62","price_state":"stated","total_value":205148.12,"total_display":"205,148.12","shares_owned_after":575000.0,"shares_owned_after_display":"575,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-01","filed_date":"2017-11-02","scope":"insider"},{"id":5320859,"accession":"0001209191-17-058948","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-17-058948","line_url":"/filing/0001209191-17-058948#line-7","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6926.0,"shares_display":"6,926","price_per_share":29.62,"price_display":"29.62","price_state":"stated","total_value":205148.12,"total_display":"205,148.12","shares_owned_after":575000.0,"shares_owned_after_display":"575,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-01","filed_date":"2017-11-02","scope":"insider"},{"id":5320856,"accession":"0001209191-17-058948","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-17-058948","line_url":"/filing/0001209191-17-058948#line-6","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25828.0,"shares_display":"25,828","price_per_share":29.04,"price_display":"29.04","price_state":"stated","total_value":750045.12,"total_display":"750,045.12","shares_owned_after":624172.0,"shares_owned_after_display":"624,172","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-10-31","filed_date":"2017-11-02","scope":"insider"},{"id":5320853,"accession":"0001209191-17-058948","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-17-058948","line_url":"/filing/0001209191-17-058948#line-5","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25827.0,"shares_display":"25,827","price_per_share":29.04,"price_display":"29.04","price_state":"stated","total_value":750016.08,"total_display":"750,016.08","shares_owned_after":624173.0,"shares_owned_after_display":"624,173","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-10-31","filed_date":"2017-11-02","scope":"insider"},{"id":5320851,"accession":"0001209191-17-058948","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-058948","line_url":"/filing/0001209191-17-058948#line-4","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23123.0,"shares_display":"23,123","price_per_share":29.96,"price_display":"29.96","price_state":"stated","total_value":692765.08,"total_display":"692,765.08","shares_owned_after":601050.0,"shares_owned_after_display":"601,050","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-10-31","filed_date":"2017-11-02","scope":"insider"},{"id":5320848,"accession":"0001209191-17-058948","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-058948","line_url":"/filing/0001209191-17-058948#line-3","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23122.0,"shares_display":"23,122","price_per_share":29.96,"price_display":"29.96","price_state":"stated","total_value":692735.12,"total_display":"692,735.12","shares_owned_after":601050.0,"shares_owned_after_display":"601,050","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-10-31","filed_date":"2017-11-02","scope":"insider"},{"id":5320845,"accession":"0001209191-17-058948","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-058948","line_url":"/filing/0001209191-17-058948#line-2","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1050.0,"shares_display":"1,050","price_per_share":30.51,"price_display":"30.51","price_state":"stated","total_value":32035.5,"total_display":"32,035.50","shares_owned_after":600000.0,"shares_owned_after_display":"600,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-10-31","filed_date":"2017-11-02","scope":"insider"},{"id":5320842,"accession":"0001209191-17-058948","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-058948","line_url":"/filing/0001209191-17-058948#line-1","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704317","owner_name":"Coric Vlad","owner_url":"/insider/0001704317","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1050.0,"shares_display":"1,050","price_per_share":30.51,"price_display":"30.51","price_state":"stated","total_value":32035.5,"total_display":"32,035.50","shares_owned_after":600000.0,"shares_owned_after_display":"600,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-10-31","filed_date":"2017-11-02","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":44,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":22,"open_market":true},{"code":"S","label":"Open-market sale","n":22,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":44},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001827635","name":"Veradermics, Inc","url":"/issuer/0001827635","role":"Director","n_filings":1,"first_seen":"2026-02-05","last_seen":"2026-02-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001935979","name":"Biohaven Ltd.","url":"/issuer/0001935979","role":"Director, Officer (Chief Executive Officer)","n_filings":8,"first_seen":"2022-10-06","last_seen":"2025-11-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001689813","name":"Biohaven Pharmaceutical Holding Co Ltd.","url":"/issuer/0001689813","role":"Director, Officer (Chief Executive Officer)","n_filings":4,"first_seen":"2017-11-02","last_seen":"2019-06-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001704317","retrieved_at":"2026-08-21T02:05:41+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}